VOLUME 6 (2015)
View Archive »
About The Cover
Mdm2 inhibition confers protection of p53-proficient cells from the cytotoxic effects of Wee1 inhibitors.
See Li et al.
Table of Contents
Editorial
|
| The cerebral cavernous malformations proteins |
|
https://doi.org/10.18632/oncotarget.5443
|
| 32279-32280 |
|
| ENT1 and treatment of viral diseases |
|
https://doi.org/10.18632/oncotarget.5859
|
| 32281-32282 |
|
| Cancer metabolism of cone photoreceptors |
|
https://doi.org/10.18632/oncotarget.5963
|
| 32285-32286 |
|
| Stathmin drives virusinduced metastasis |
|
https://doi.org/10.18632/oncotarget.5961
|
| 32289-32290 |
|
| Armt1: a phoenix rises from the ashes |
|
https://doi.org/10.18632/oncotarget.5964
|
| 32291-32292 |
|
| Hsp70 proteins in mitosis and disease |
|
https://doi.org/10.18632/oncotarget.5965
|
| 32293-32294 |
|
| MicroRNAs T follicular helper cells and inflammaging |
|
https://doi.org/10.18632/oncotarget.6025
|
| 32295-32296 |
Editorial: Immunology
|
| HSP60 – a double edge sword in autoimmunity |
|
https://doi.org/10.18632/oncotarget.5869
|
| 32299-32300 |
|
| The negative NK cell maturation checkpoint Foxo1 |
|
https://doi.org/10.18632/oncotarget.6109
|
| 32301-32302 |
|
| Pathogenic Th2 Tpath2 cells in airway inflammation |
|
https://doi.org/10.18632/oncotarget.6033
|
| 32303-32304 |
|
| The flavors of plasma cells |
|
https://doi.org/10.18632/oncotarget.4631
|
| 32305-32306 |
|
| Adenosine: a selfishimmunity signal |
|
https://doi.org/10.18632/oncotarget.4685
|
| 32307-32308 |
|
| PTX3 acts as an extrinsic oncosuppressor |
|
https://doi.org/10.18632/oncotarget.4845
|
| 32309-32310 |
|
| Tuning B cell responsiveness by antigen receptor isotype |
|
https://doi.org/10.18632/oncotarget.4880
|
| 32311-32312 |
|
| Immunosuppressive arenaviral exoribonuclease |
|
https://doi.org/10.18632/oncotarget.6110
|
| 32315-32316 |
Research Perspectives
|
| Cancer stem celldriven efficacy of trastuzumab Herceptin: towards a reclassification of clinically HER2positive breast carcinomas |
|
https://doi.org/10.18632/oncotarget.6094
|
| 32317-32338 |
Priority Research Papers
|
| Mdm2 inhibition confers protection of p53proficient cells from the cytotoxic effects of Wee1 inhibitors |
|
https://doi.org/10.18632/oncotarget.5891
|
| 32339-32352 |
|
| Caspase 3 in dying tumor cells mediates postirradiation angiogenesis |
|
https://doi.org/10.18632/oncotarget.5898
|
| 32353-32367 |
|
| Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for <em>KRAS</em> mutant tumors |
|
https://doi.org/10.18632/oncotarget.5941
|
| 32368-32379 |
|
| Direct inhibition of cMycMax heterodimers by celastrol and celastrolinspired triterpenoids |
|
https://doi.org/10.18632/oncotarget.6116
|
| 32380-32395 |
|
| Common cancerassociated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition |
|
https://doi.org/10.18632/oncotarget.6136
|
| 32396-32409 |
Research Papers: Immunology
|
| NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2 |
|
https://doi.org/10.18632/oncotarget.5609
|
| 32410-32425 |
|
| Antigen spreadinginduced CD8<sup>+</sup>T cells confer protection against the lethal challenge of wildtype malignant mesothelioma by eliminating myeloidderived suppressor cells |
|
https://doi.org/10.18632/oncotarget.5856
|
| 32426-32438 |
|
| Bortezomib enhances expression of effector molecules in antitumor CD8<sup>+</sup> T lymphocytes by promoting Notchnuclear factorκB crosstalk |
|
https://doi.org/10.18632/oncotarget.5857
|
| 32439-32455 |
|
| Lack of intracellular replication of <em>M tuberculosis</em> and <em>M bovis</em> BCG caused by delivering bacilli to lysosomes in murine brain microvascular endothelial cells |
|
https://doi.org/10.18632/oncotarget.5932
|
| 32456-32467 |
|
| Piperine metabolically regulates peritoneal resident macrophages to potentiate their functions against bacterial infection |
|
https://doi.org/10.18632/oncotarget.5957
|
| 32468-32483 |
|
| Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area |
|
https://doi.org/10.18632/oncotarget.5398
|
| 32484-32493 |
|
| DNAmediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies |
|
https://doi.org/10.18632/oncotarget.5572
|
| 32494-32508 |
Reviews
|
| The search for <i>cis</i>regulatory driver mutations in cancer genomes |
|
https://doi.org/10.18632/oncotarget.5085
|
| 32509-32525 |
Research Papers
|
| Hydrogen peroxide inducible clone5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression |
|
https://doi.org/10.18632/oncotarget.5322
|
| 32526-32544 |
|
| MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.5324
|
| 32545-32560 |
|
| An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer |
|
https://doi.org/10.18632/oncotarget.4935
|
| 32561-32574 |
|
| EMMPRIN regulates tumor growth and metastasis by recruiting bone marrowderived cells through paracrine signaling of SDF1 and VEGF |
|
https://doi.org/10.18632/oncotarget.5331
|
| 32575-32585 |
|
| MicroRNA506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2 |
|
https://doi.org/10.18632/oncotarget.5309
|
| 32586-32601 |
|
| Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology |
|
https://doi.org/10.18632/oncotarget.5289
|
| 32602-32609 |
|
| TQ inhibits hepatocellular carcinoma growth <i>in vitro</i> and <i>in vivo</i> via repression of Notch signaling |
|
https://doi.org/10.18632/oncotarget.5362
|
| 32610-32621 |
|
| Acquired resistance to 5fluorouracil <i>via</i> HSP90/Srcmediated increase in thymidylate synthase expression in colon cancer |
|
https://doi.org/10.18632/oncotarget.5327
|
| 32622-32633 |
|
| Normal mammary epithelial cells promote carcinoma basement membrane invasion by inducing microtubulerich protrusions |
|
https://doi.org/10.18632/oncotarget.4728
|
| 32634-32645 |
|
| Acquisition of a single EZH2 D1 domain mutation confers acquired resistance to EZH2targeted inhibitors |
|
https://doi.org/10.18632/oncotarget.5066
|
| 32646-32655 |
|
| p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer |
|
https://doi.org/10.18632/oncotarget.5328
|
| 32656-32668 |
|
| A CD21 low phenotype with no evidence of autoantibodies to complement proteins is consistent with a poor prognosis in CLL |
|
https://doi.org/10.18632/oncotarget.5404
|
| 32669-32680 |
|
| A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment |
|
https://doi.org/10.18632/oncotarget.5354
|
| 32681-32700 |
|
| MiR373 drives the epithelialtomesenchymal transition and metastasis via the miR373TXNIPHIF1αTWIST signaling axis in breast cancer |
|
https://doi.org/10.18632/oncotarget.4702
|
| 32701-32712 |
|
| PDGF activation in PGDSpositive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with <i>Nf2</i> and <i>Cdkn2ab</i> loss |
|
https://doi.org/10.18632/oncotarget.5296
|
| 32713-32722 |
|
| RhoGDI deficiency induces constitutive activation of Rho GTPases and COX2 pathways in association with breast cancer progression |
|
https://doi.org/10.18632/oncotarget.5416
|
| 32723-32736 |
|
| MicroRNA99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.5355
|
| 32737-32747 |
|
| Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells |
|
https://doi.org/10.18632/oncotarget.4977
|
| 32748-32760 |
|
| Flcndeficient renal cells are tumorigenic and sensitive to mTOR suppression |
|
https://doi.org/10.18632/oncotarget.5018
|
| 32761-32773 |
|
| miR134 in extracellular vesicles reduces triplenegative breast cancer aggression and increases drug sensitivity |
|
https://doi.org/10.18632/oncotarget.5192
|
| 32774-32789 |
|
| Synergistic anticancer effects of triptolide and celastrol two main compounds from thunder god vine |
|
https://doi.org/10.18632/oncotarget.5411
|
| 32790-32804 |
|
| MiR200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.5352
|
| 32805-32820 |
|
| Downregulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells |
|
https://doi.org/10.18632/oncotarget.5104
|
| 32821-32840 |
|
| Suppressor of Ty homolog5 a novel tumorspecific human telomerase reverse transcriptase promoterbinding protein and activator in colon cancer cells |
|
https://doi.org/10.18632/oncotarget.5301
|
| 32841-32855 |
|
| Antitumoral activity of the mithralog EC8042 in triple negative breast cancer linked to cell cycle arrest in G2 |
|
https://doi.org/10.18632/oncotarget.5942
|
| 32856-32867 |
|
| Circulating microRNA signature as liquidbiopsy to monitor lung cancer in lowdose computed tomography screening |
|
https://doi.org/10.18632/oncotarget.5210
|
| 32868-32877 |
|
| Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.5419
|
| 32878-32889 |
|
| LYAR promotes colorectal cancer cell mobility by activating galectin1 expression |
|
https://doi.org/10.18632/oncotarget.5335
|
| 32890-32901 |
|
| IL13 receptor α2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice |
|
https://doi.org/10.18632/oncotarget.5361
|
| 32902-32913 |
|
| Na<sub>v</sub>15 regulates breast tumor growth and metastatic dissemination <i>in vivo</i> |
|
https://doi.org/10.18632/oncotarget.5441
|
| 32914-32929 |
|
| Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells <i>in vitro</i> and <i>in vivo</i> |
|
https://doi.org/10.18632/oncotarget.5405
|
| 32930-32943 |
|
| MiR208a stimulates the cocktail of SOX2 and βcatenin to inhibit the let7 induction of selfrenewal repression of breast cancer stem cells and formed miR208a/let7 feedback loop via LIN28 and DICER1 |
|
https://doi.org/10.18632/oncotarget.5079
|
| 32944-32954 |
|
| Deciphering the molecular basis of invasiveness in <i>Sdhb</i>deficient cells |
|
https://doi.org/10.18632/oncotarget.5106
|
| 32955-32965 |
|
| IL17 producing mast cells promote the expansion of myeloidderived suppressor cells in a mouse allergy model of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.5435
|
| 32966-32979 |
|
| Immature myeloid progenitors promote disease progression in a mouse model of Barrett’slike metaplasia |
|
https://doi.org/10.18632/oncotarget.5431
|
| 32980-33005 |
|
| Twist1mediated 4EBP1 regulation through mTOR in nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.5026
|
| 33006-33018 |
|
| PDL1 is remarkably overexpressed in EBVassociated pulmonary lymphoepitheliomalike carcinoma and related to poor diseasefree survival |
|
https://doi.org/10.18632/oncotarget.5028
|
| 33019-33032 |
|
| Breast cancer associated a2 isoform vacuolar ATPase immunomodulates neutrophils: potential role in tumor progression |
|
https://doi.org/10.18632/oncotarget.5439
|
| 33033-33045 |
|
| Repurposing the antimalarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth metastasis and angiogenesis |
|
https://doi.org/10.18632/oncotarget.5422
|
| 33046-33064 |
|
| Lysinespecific demethylase 1 promotes tumorigenesis and predicts prognosis in gallbladder cancer |
|
https://doi.org/10.18632/oncotarget.5279
|
| 33065-33076 |
|
| Downregulation of IKKβ expression in gliomainfiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma |
|
https://doi.org/10.18632/oncotarget.5310
|
| 33077-33090 |
|
| Sur8/Shoc2 promotes cell motility and metastasis through activation of RasPI3K signaling |
|
https://doi.org/10.18632/oncotarget.5173
|
| 33091-33105 |
|
| Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA |
|
https://doi.org/10.18632/oncotarget.5851
|
| 33106-33119 |
|
| Isolation and characterization of novel <i>RECK</i> tumor suppressor gene splice variants |
|
https://doi.org/10.18632/oncotarget.5305
|
| 33120-33133 |
|
| tDarpp overexpression in HER2positive breast cancer confers a survival advantage in lapatinib |
|
https://doi.org/10.18632/oncotarget.5311
|
| 33134-33145 |
|
| Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre and postmenopausal ranges |
|
https://doi.org/10.18632/oncotarget.5082
|
| 33146-33164 |
|
| Vesicular stomatitis virus expressing interferonβ is oncolytic and promotes antitumor immune responses in a syngeneic murine model of nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.5320
|
| 33165-33177 |
|
| p73 regulates basal and starvationinduced liver metabolism <i>in vivo</i> |
|
https://doi.org/10.18632/oncotarget.5090
|
| 33178-33190 |
|
| Extracting tumor tissue immune status from expression profiles: correlating renal cancer prognosis with tumorassociated immunome |
|
https://doi.org/10.18632/oncotarget.5052
|
| 33191-33205 |
|
| Preclinical evidence of PIM kinase inhibitor activity in BCRABL1 unmutated and mutated Philadelphia chromosomepositive Ph+ leukemias |
|
https://doi.org/10.18632/oncotarget.5091
|
| 33206-33216 |
|
| High frequency of additional gene mutations in acute myeloid leukemia with <i>MLL</i> partial tandem duplication: <i>DNMT3A</i> mutation is associated with poor prognosis |
|
https://doi.org/10.18632/oncotarget.5202
|
| 33217-33225 |
|
| Cigarette sidestream smoke lung and bladder carcinogenesis: inducing mutagenic acroleinDNA adducts inhibiting DNA repair and enhancing anchorageindependentgrowth cell transformation |
|
https://doi.org/10.18632/oncotarget.5429
|
| 33226-33236 |
|
| An epigenetic autofeedback loop regulates TGFβ type II receptor expression and function in NSCLC |
|
https://doi.org/10.18632/oncotarget.4893
|
| 33237-33252 |
|
| A common promoter hypomethylation signature in invasive breast liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness |
|
https://doi.org/10.18632/oncotarget.5291
|
| 33253-33268 |
|
| Targeting of RUNX3 by miR130a and miR495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells |
|
https://doi.org/10.18632/oncotarget.5037
|
| 33269-33278 |
|
| Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L |
|
https://doi.org/10.18632/oncotarget.5337
|
| 33279-33289 |
|
| Simultaneous targeting of 5LOXCOX and EGFR blocks progression of pancreatic ductal adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.5396
|
| 33290-33305 |
|
| Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications |
|
https://doi.org/10.18632/oncotarget.5089
|
| 33306-33318 |
|
| Genomic landscape of endometrial stromal sarcoma of uterus |
|
https://doi.org/10.18632/oncotarget.5384
|
| 33319-33328 |
|
| Depletion of mucin in mucinproducing human gastrointestinal carcinoma: Results from <i>in vitro</i> and <i>in vivo</i> studies with bromelain and Nacetylcysteine |
|
https://doi.org/10.18632/oncotarget.5259
|
| 33329-33344 |
|
| Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via upregulation of ABCA1 expression |
|
https://doi.org/10.18632/oncotarget.5428
|
| 33345-33357 |
|
| The NEXT1 Next generation pErsonalized tX with mulTiomics and preclinical model trial: prospective molecular screening trial of metastatic solid cancer patients a feasibility analysis |
|
https://doi.org/10.18632/oncotarget.5188
|
| 33358-33368 |
|
| Lowered circulating aspartate is a metabolic feature of human breast cancer |
|
https://doi.org/10.18632/oncotarget.5409
|
| 33369-33381 |
|
| Nonthermal plasma induces AKT degradation through turnon the MUL1 E3 ligase in head and neck cancer |
|
https://doi.org/10.18632/oncotarget.5407
|
| 33382-33396 |
|
| BRD4targeted therapy induces Mycindependent cytotoxicity in Gnaq/11mutatant uveal melanoma cells |
|
https://doi.org/10.18632/oncotarget.5179
|
| 33397-33409 |
|
| TLAK celloriginated protein kinase presents a novel therapeutic target in <i>FLT3</i>ITD mutated acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.5418
|
| 33410-33425 |
|
| Role of Ncadherin in proliferation migration and invasion of germ cell tumours |
|
https://doi.org/10.18632/oncotarget.5288
|
| 33426-33437 |
|
| Cranberry proanthocyanidins inhibit esophageal adenocarcinoma <em>in vitro</em> and <em>in vivo</em> through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation |
|
https://doi.org/10.18632/oncotarget.5586
|
| 33438-33455 |
|
| Expression profile of innate immune receptors NLRs and AIM2 in human colorectal cancer: correlation with cancer stages and inflammasome components |
|
https://doi.org/10.18632/oncotarget.5587
|
| 33456-33469 |
|
| Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by upregulating SOX18 in human gastric cancer |
|
https://doi.org/10.18632/oncotarget.5272
|
| 33470-33485 |
|
| CD19<sup>+</sup>CD24<sup>hi</sup>CD38<sup>hi</sup>Bregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer |
|
https://doi.org/10.18632/oncotarget.5588
|
| 33486-33499 |
|
| Prostaglandin E receptor 4 EP4 promotes colonic tumorigenesis |
|
https://doi.org/10.18632/oncotarget.5589
|
| 33500-33511 |
|
| MT1MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1MMP driven melanoma cell motility |
|
https://doi.org/10.18632/oncotarget.5258
|
| 33512-33522 |
|
| Golgi protein 73 activation of MMP13 promotes hepatocellular carcinoma cell invasion |
|
https://doi.org/10.18632/oncotarget.5590
|
| 33523-33533 |
|
| Targeting the membraneanchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden |
|
https://doi.org/10.18632/oncotarget.5214
|
| 33534-33553 |
|
| The NFκB p65/miR23a27a24 cluster is a target for leukemia treatment |
|
https://doi.org/10.18632/oncotarget.5591
|
| 33554-33567 |
|
| Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation |
|
https://doi.org/10.18632/oncotarget.5598
|
| 33568-33586 |
|
| Long noncoding RNA HOXAAS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression |
|
https://doi.org/10.18632/oncotarget.5599
|
| 33587-33601 |
|
| The panHER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulinmediated resistance to EGFR inhibitors in nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.5286
|
| 33602-33611 |
|
| The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients |
|
https://doi.org/10.18632/oncotarget.5600
|
| 33612-33622 |
|
| Induction of USP17 by combining BET and HDAC inhibitors in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.5601
|
| 33623-33635 |
|
| SIP1 is a downstream effector of GADD45G in senescence induction and growth inhibition of liver tumor cells |
|
https://doi.org/10.18632/oncotarget.5602
|
| 33636-33647 |
|
| GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells |
|
https://doi.org/10.18632/oncotarget.5203
|
| 33648-33657 |
|
| GRP78 confers the resistance to 5FU by activating the cSrc/LSF/TS Axis in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.5603
|
| 33658-33674 |
|
| Heme oxygenase1 in macrophages controls prostate cancer progression |
|
https://doi.org/10.18632/oncotarget.5284
|
| 33675-33688 |
|
| Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota |
|
https://doi.org/10.18632/oncotarget.5604
|
| 33689-33704 |
|
| HSulf1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.5605
|
| 33705-33719 |
|
| Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent celldeath pathway in HNSCC |
|
https://doi.org/10.18632/oncotarget.5606
|
| 33720-33732 |
|
| Imaging of carbonic anhydrase IX with an <sup>111</sup>Inlabeled dualmotif inhibitor |
|
https://doi.org/10.18632/oncotarget.5254
|
| 33733-33742 |
|
| ARv7 protein expression is regulated by protein kinase and phosphatase |
|
https://doi.org/10.18632/oncotarget.5608
|
| 33743-33754 |
|
| Apoptosis induced by temozolomide and nimustine in glioblastoma cells is supported by JNK/cJunmediated induction of the BH3only protein BIM |
|
https://doi.org/10.18632/oncotarget.5274
|
| 33755-33768 |
|
| Pyrvinium selectively targets blast phasechronic myeloid leukemia through inhibition of mitochondrial respiration |
|
https://doi.org/10.18632/oncotarget.5615
|
| 33769-33780 |
|
| Dendritic cell vaccination with a tolllike receptor agonist derived from mycobacteria enhances antitumor immunity |
|
https://doi.org/10.18632/oncotarget.5281
|
| 33781-33790 |
|
| HBxrelated long noncoding RNA DBHAS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.5667
|
| 33791-33804 |
|
| MUC4promoted neural invasion is mediated by the axon guidance factor netrin1 in PDAC |
|
https://doi.org/10.18632/oncotarget.5668
|
| 33805-33822 |
|
| Differential expression and biochemical activity of the immune receptor Tim3 in healthy and malignant human myeloid cells |
|
https://doi.org/10.18632/oncotarget.5257
|
| 33823-33833 |
|
| The association between let7 RAS and HIF1α in Ewing Sarcoma tumor growth |
|
https://doi.org/10.18632/oncotarget.5616
|
| 33834-33848 |
|
| Primary CNS lymphoproliferative disease mycophenolate and calcineurin inhibitor usage |
|
https://doi.org/10.18632/oncotarget.5292
|
| 33849-33866 |
|
| EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.5293
|
| 33867-33877 |
|
| BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas |
|
https://doi.org/10.18632/oncotarget.5302
|
| 33878-33892 |
|
| The metastasis suppressor NDRG1 inhibits “stemness†of colorectal cancer <i>v</i>ia downregulation of nuclear βcatenin and CD44 |
|
https://doi.org/10.18632/oncotarget.5294
|
| 33893-33911 |
Clinical Research Papers
|
| Lymph node ratio is a prognostic factor for nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.5669
|
| 33912-33918 |
|
| The value of forceps biopsy and core needle biopsy in prediction of pathologic complete remission in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy |
|
https://doi.org/10.18632/oncotarget.5287
|
| 33919-33925 |
|
| The efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced locally recurrent nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.5271
|
| 33926-33934 |
|
| Comparison of survival and clinicopathologic features in colorectal cancer among African American Caucasian and Chinese patients treated in the United States: Results from the surveillance epidemiology and end results SEER database |
|
https://doi.org/10.18632/oncotarget.5223
|
| 33935-33943 |
|
| Effects of first and secondgeneration tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem |
|
https://doi.org/10.18632/oncotarget.5580
|
| 33944-33951 |
|
| Reducing the probability of radiationinduced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixedbeam intensitymodulated radiotherapy |
|
https://doi.org/10.18632/oncotarget.5581
|
| 33952-33960 |
|
| Efficiency of CD19 chimeric antigen receptormodified T cells for treatment of B cell malignancies in phase I clinical trials: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.5582
|
| 33961-33971 |
|
| High PDL1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer |
|
https://doi.org/10.18632/oncotarget.5583
|
| 33972-33981 |
|
| Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management |
|
https://doi.org/10.18632/oncotarget.5053
|
| 33982-33992 |
|
| <i>RET</i> mutation pS891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding <i>OSMR</i> variant pG513D |
|
https://doi.org/10.18632/oncotarget.4992
|
| 33993-34003 |
|
| Changes in expression levels of <em>ERCC1 DPYD</em> and <em>VEGFA</em> mRNA after firstline chemotherapy of metastatic colorectal cancer: results of a multicenter study |
|
https://doi.org/10.18632/oncotarget.5227
|
| 34004-34013 |
|
| <em>KRAS</em> mutations affect prognosis of nonsmallcell lung cancer patients treated with firstline platinum containing chemotherapy |
|
https://doi.org/10.18632/oncotarget.5607
|
| 34014-34022 |
|
| Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province |
|
https://doi.org/10.18632/oncotarget.5850
|
| 34023-34029 |
Case Reports
|
| Afatinib an irreversible ErbB family blocker with protracted temozolomide in recurrent glioblastoma: A case report |
|
https://doi.org/10.18632/oncotarget.5297
|
| 34030-34037 |
Errata
|
| Erratum: Trop2 is upregulated in invasive prostate cancer and displaces FAK from focal contacts |
|
https://doi.org/10.18632/oncotarget.6187
|
| 34038 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
